North Am
The decline in DPP-4 usages is likely due to the fact that most are not effective in combination with GLPs
X.M.s institution has received compensation for lecture honoraria and travel expenses, participation in scientific meetings, clinical trial steering committee membership or clinical advisory board participation from AbbVie, Actelion, Alexion, Bial, Biogen, Bristol Myers Squibb (Celgene), EMD Serono, Genzyme, Immunic Therapeutics, Janssen Pharmaceuticals, Medday, Merck, Mylan, Nervgen, Neuraxpharm, Novartis, Peervoice, Roche, Samsung-Biosys, Sandoz, Sanofi-Genzyme, Teva Pharmaceutical, TG Therapeutics and Excemed
He said it could also help inform dietary advice, helping patients find alternatives to foods that have become less appealing